The 510(k) submission for the HeartBeam system continues to progress through active review by the FDA. The Company has successfully responded to the questions asked by the FDA and is currently ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has reported its ...

Cash Balance: $5.8 million as of September 30, 2024. HeartBeam Inc (NASDAQ:BEAT) has developed a groundbreaking cable-free 12-lead ECG technology that can be used by patients anywhere, offering ...

Continued Clinical and Regulatory Progress on the HeartBeam System Key Appointments to Management Team Completed as Part of Planned Evolution in Preparation for US Commercialization Strengthening ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights wherever the patient ...

Continued Clinical and Regulatory Progress on the HeartBeam System Key Appointments to Management Team Completed as Part of Planned Evolution in Preparation for US Commercialization Strengthening ...

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has reported its financial and operational results for ...

Greetings, and welcome to the HeartBeam Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. Before we begin the ...

Heartbeam, Inc. ( (BEAT)) has released its Q3 earnings. Here is a breakdown of the information Heartbeam, Inc. presented to its investors. HeartBeam, Inc. is an innovative medical technology ...

The Company continues to make steady progress toward key clinical and regulatory milestones on the HeartBeam system. Branislav Vajdic, Ph.D., Founder of HeartBeam, appointed as President.

HeartBeam ( (BEAT)) has provided an update. HeartBeam, Inc. has appointed Robert Eno as the new CEO, effective October 21, 2024, to lead the company through commercialization and growth of its ...

Company Receives Top Honors in the ‘Home Health Diagnostic’ Category for its Groundbreaking Technology that Captures the Heart’s Electrical Signals from Three Dimensions HeartBeam ...